(Q33537440)

27 July 2017

1 reference

title

Pharmacological management of diabetes: recent progress and future perspective in daily drug treatment (English)

1 reference

27 July 2017

Emilien G

1

1 reference

27 July 2017

Maloteaux JM

series ordinal

2

1 reference

27 July 2017

Ponchon M

series ordinal

3

1 reference

27 July 2017

publication date

1 January 1999

1 reference

Pharmacology & Therapeutics

27 July 2017

published in

1 reference

27 July 2017

volume

81

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

37-51

1 reference

Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

1 reference

7 January 2021

Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

The new era of biotech insulin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Monomeric insulins obtained by protein engineering and their medical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

BRL 35135, a potent and selective atypical beta-adrenoceptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

In vitro studies on the action of CS-045, a new antidiabetic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Pathogenesis of NIDDM. A balanced overview

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Double-blind evaluation of efficacy and tolerability of metformin in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

New non-sulfonylurea insulin secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Treatment of NIDDM with insulin agonists or substitutes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Insulin resistance with respect to lipolysis in non-diabetic relatives of European patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Sulfonylureas in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Severe insulin resistance treated with insulin lispro

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Prevalence and secular trends in obesity in Pacific and Indian Ocean island populations

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Comparison of LysB28, ProB29-human insulin analog and regular human insulin in the correction of incidental hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Long-term effect of acarbose on glycaemic control in non-insulin-dependent diabetes mellitus: a placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

A novel antidiabetic drug, troglitazone--reason for hope and concern

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Identification of microsatellite markers near the human genes encoding the beta-cell ATP-sensitive K+ channel and linkage studies with NIDDM in Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Comparison of tolbutamide and metformin in elderly diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

alpha-Glucosidase inhibition by miglitol in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Cellular mechanism of action of metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

An epidemiological perspective of the relationship between physical activity and NIDDM: from activity assessment to intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

New therapeutic agents for the treatment of NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Effect of troglitazone on steady-state pharmacokinetics of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Stability of insulin lispro in insulin infusion systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Lactic acidosis in patients with diabetes treated with metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Ultrasound-mediated transdermal protein delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Amperometric glucose microelectrodes prepared through immobilization of glucose oxidase in redox hydrogels

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

The kinetics of peritoneal insulin absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Glycogen synthase: a putative locus for diet-induced hyperglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Genetic analysis of type 1 diabetes using whole genome approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Metformin kinetics in healthy subjects and in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Hepatic dysfunction associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Section Review: Oncologic, Endocrine & Metabolic: Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Insulin analogues: new agents for improving glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Disruption of IRS-2 causes type 2 diabetes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Role of insulin resistance in the pathogenesis of NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900034-5

7 January 2021

10.1016/S0163-7258(98)00034-5

Identifiers

DOI

1 reference

release_b3dw2gcdp5cljlwl4cfvr4vnry

27 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b3dw2gcdp5cljlwl4cfvr4vnry

24 November 2022

mapped directly with Wikidata item

1 reference